DRNA - Dicerna Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

Dicerna Pharmaceuticals's activity chart (see below) currently has 94 price targets and 69 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 79.09% of the time, taking 356.54 days on average.

Most recent stock forecast was given by KEAY NAKAE from CHARDAN CAPITAL on 10-Dec-2021.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 02-Mar-2021

$38.25

$28

4 years 11 months 12 days ago
(10-Dec-2021)

2/3 (66.67%)

$0.34 (0.90%)

101

Buy Since 13-May-2020

$38.25

5 years 2 days ago
(20-Nov-2021)

3/3 (100%)

$0.33 (0.87%)

171

Buy Since 13-Sep-2018

$38

5 years 3 days ago
(19-Nov-2021)

9/11 (81.82%)

$-0.03 (-0.08%)

277

Buy Since 12-Mar-2019

$35

$35

5 years 4 days ago
(18-Nov-2021)

4/7 (57.14%)

$-3.03 (-7.97%)

243

Buy Since 06-Nov-2018

$25

5 years 3 months 11 days ago
(11-Aug-2021)

6/10 (60%)

$2.81 (12.66%)

241

Show more analysts

Please expand the browser size to see the chart

What is DRNA (Dicerna Pharmaceuticals) average time for price targets to be met?

On average it took 357 days for the stock forecasts to be reached, with an average price target met ratio of 79.09%.

Which analyst most recently updated their price target on DRNA (Dicerna Pharmaceuticals)?

Keay Nakae

Which analyst has the most public recommendations on DRNA (Dicerna Pharmaceuticals)?

Keay Nakae works at CHARDAN CAPITAL and has 5 price targets and 3 ratings on DRNA

Which analyst is the currently most bullish on DRNA (Dicerna Pharmaceuticals)?

Keay Nakae with the highest potential upside of $0.03

Which analyst is the currently most reserved on DRNA (Dicerna Pharmaceuticals)?

Shaunak Deepak with the lowest potential downside of -$33.22
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?